REQUEST A DEMO
Total
USD $0.00
Search more companies

Duchembio Co. Ltd. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Duchembio Co. Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Duchembio Co. Ltd. is a company based in South Korea, with its head office in Seoul. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on April 10, 2026. 141 (2024) employees currently work for Duchembio Co. Ltd.. The latest financial highlights indicate a net sales revenue increase of 2.61% in 2024. Over the same period, its total assets grew by 32.25%. In 2024, Duchembio Co. Ltd.’s net profit margin increased by 10.92%.

Headquarters
4F, 47, Kyonggidae-Ro, Seodaemun-Gu
Seoul; Seoul;

Contact Details: Purchase the Duchembio Co. Ltd. report to view the information.

Website: http://duchem.rootshell.co.kr

Basic Information
Total Employees:
Purchase the Duchembio Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Duchembio Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Duchembio Co. Ltd. report to view the information.
Incorporation Date:
April 10, 2026
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Subsidiaries
(주)듀켐바이오연구소
(주)씨코헬스케어
Khealth Corporation
Company Performance
Financial values in the chart are available after Duchembio Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
2.61%
Total Operating Revenue
5.88%
Operating Profit
18.92%
EBITDA
8.3%
Net Profit/Loss for the Period
99.82%
Total Assets
32.25%
Total Equity
97.34%
Operating Profit Margin
2.39%
Net Profit Margin
10.92%
Return on Equity (ROE)
0.23%
Debt / Equity
-59013%
Quick Ratio
815.84%
Cash Ratio
0.62%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?